Exploring ICP-MS expertise at Almac
A discussion about Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and its importance within drug development.
Drug Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Breaking News | Drug Development | Industry News
BioVersys Gets EIB Funds to Address Antimicrobial Resistance
Financing supports development of BioVersys’ breakthrough hospital antibiotic therapy targeting Acinetobacter baumanniiKristin Brooks 04.14.21
-
APIs | Drug Development | Process Validation
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
FDA Accepts Airway Therapeutics’ IND for COVID Treatment
To initiate a Phase 1b trial to confirm the feasibility of intratracheal administrations of AT-100 and its beneficial safety and tolerability profile.Kristin Brooks 04.12.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi Acquires Tidal Therapeutics
Gains novel mRNA-based technology with research capabilities in immuno-oncology and inflammatory diseases, with potential in other disease areas.Kristin Brooks 04.12.21
-
Analytical Services | Breaking News | Clinical Trial Materials | Drug Development | Industry News
Ascendia Pharmaceuticals Poised for Expansion
CDMO secures growth equity investment from Signet Healthcare Partners.Tim Wright, Editor, Contract Pharma 04.09.21
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News
Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
Work together to develop and commercialize CHI’s novel dry-powder inhaler product.Charles Sternberg, Assistant Editor 04.07.21
-
Breaking News | Clinical Trials | Drug Development | Industry News
Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment
To support the testing of SPI-1005 in two Phase 2 clinical trials for the treatment of COVID-19.Kristin Brooks 04.06.21
-
Breaking News | Clinical Trials | CRO News | Drug Development
Moleculin Selects IQVIA Biotech to Advance COVID Treatment
IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.Kristin Brooks 04.06.21
-
Clinical Trials | Drug Development | QA/QC
RBQM Comes of Age: COVID as a Catalyst for Change
Clinical trial conduct has undergone a fundamental shift over the last year – and things will never be the same again.Online Exclusives Kristin Brooks, Managing Editor 04.01.21
-
Breaking News | Drug Development
Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio
Expands its oncology leadership capabilities in the U.S.Charles Sternberg, Assistant Editor 04.01.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
Combined company brings complementary Ribosomal RNA-targeted genetic therapy platforms together.Kristin Brooks 04.01.21
-
Clinical Trial Materials | Drug Development | Formulation Development
On-Demand Webinar: Accelerated Timelines for Clinical Supply Manufacture
Watch this on-demand webinar to gain a deeper understanding of the value of adaptive processes at this critical early stage of drug development.
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Ajinomoto, Bright Peak Enter Immunocytokines Research Pact
Exclusive license agreement to incorporate Ajinomoto Co.’s AJICAP site-specific bioconjugation technology for the development of Bright Peak Immunocytokines.Kristin Brooks 03.30.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Facilities | Industry News
Chime Biologics Expands CDMO Capabilities
Completes $190 million financing round to accelerate capacity expansion.Tim Wright, Editor, Contract Pharma 03.29.21
-
cGMP Manufacture | Drug Development | Scale-up/Technology Transfer
Fast Track Automation in Pharmaceutical Manufacturing
Drug manufacturers turn to advanced automation technologies and project execution methodologies to reduce time, cost and riskSteve Zarichniak, Technical Solutions Consultant, Honeywell Process Solutions 03.25.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
CyanVac and Exothera Enter COVID-19 Vaccine Partnership
CDMO Exothera selected for the development and GMP manufacturing of intranasal vaccine candidate for Phase III clinical trial is Europe and the U.S.Tim Wright, Editor, Contract Pharma 03.25.21
-
Drug Development
Accelerate Your Program: Streamlined Phase Appropriate Technologies & Expertise
In this webinar on April 21, learn how the technologies of the OneXpress™ Solution can help streamline development and manufacturing and more.03.25.21
-
Breaking News | Drug Development | Facilities | Industry News | Parenterals
Eisai Begins Construction of New Injection/Research Building
To accommodate expanded drug discovery targets and new modalities such as antibodies, ADCs, and nucleic acid drugs.Kristin Brooks 03.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, Takeda Enter Multi-RNA Target Alliance
To discover and develop small molecule therapeutics for highly attractive targets that are difficult to address via more conventional approaches.Kristin Brooks 03.22.21
-
Clinical Trials | Drug Development
Regulatory Practices in a Post-Pandemic World
Envisioning the new normal for clinical development.Dr. Ronan Brown, SVP and Head of Integrated Global Compliance, IQVIA 03.22.21
